Over the last 12 months, Tenax Therapeutics insiders reported 8 buys totaling $190K and no sales across SEC Form 4 filings.
Scroll the table sideways for price, value and marks.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Dec 9, 2025 | Rich StuartChief Medical Officer · O·D | ▲ Buy | 2,500 | $10.22 | $26K | +90.4% | — |
| Dec 8, 2025 | Rich StuartChief Medical Officer · O·D | ▲ Buy | 2,500 | $10.1 | $25K | +100% | indirect |
| Dec 4, 2025 | Rich StuartChief Medical Officer · O·D | ▲ Buy | 2,500 | $9.2 | $23K | — | indirect |
| Dec 3, 2025 | Rich StuartChief Medical Officer · O·D | ▲ Buy | 2,500 | $9.05 | $23K | +939.8% | 2 tranches |
| Nov 20, 2025 | Giordano Christopher ThomasCEO · O·D | ▲ Buy | 2,605 | $7.68 | $20K | — | 3 tranches |
| Nov 18, 2025 | Almenoff June SherieD | ▲ Buy | 1,993 | $7.5 | $15K | — | 2 tranches |
| Nov 17, 2025 | MCGAULEY THOMASInterim CFO · O | ▲ Buy | 6,000 | $7.25 | $43K | — | 2 tranches · indirect |
| Nov 17, 2025 | MCGAULEY THOMASInterim CFO · O | ▲ Buy | 2,000 | $7.34 | $15K | — | — |
Form 4 filings land on this page within minutes of hitting EDGAR. A free account turns that into an email whenever Tenax Therapeutics insiders buy or sell, with the plan flag and the dollar value already read.
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $TENX feed.